(Article by Ethan Huff republished from NaturalNews.com)
The Data Safety Monitoring Board (DSMB) sent a notice both to AstraZeneca and to two government health agencies expressing worry that the England-based drug giant is using “outdated information” to declare its jab is “safe and effective.”
The board’s job involves monitoring clinical trials and reviewing data collected at regular intervals throughout the testing process. Based on what the board has uncovered thus far, it would appear that AstraZeneca is actively manipulating data in an attempt to peddle an unsafe and ineffective injection on the masses.
According to the National Institute of Allergy and Infectious Diseases (NIAID), which is headed up by the infamous Anthony Fauci, the DSMB has “expressed concern that AstraZeneca may have included outdated information” from a phase three clinical trial that “may have provided an incomplete view of the efficacy data.”
The NIAID is now urging AstraZeneca to work closely with the DSMB to ensure that the company uses and releases only the most accurate and up-to-date information. As of right now, AstraZeneca is basically lying to both regulators and the general public about the true nature of its Chinese virus injection.
According to the company, its Wuhan flu injection “was well tolerated” in phase three trials, but again this is based on incomplete and outdated information that of course benefits the company at the expense of public health.
Fauci says AstraZeneca jab is “safe and effective” despite fraudulent data
Despite all this, Fauci says that AstraZeneca’s experimental gene therapy injection is still “likely … very good.”
During a recent appearance on ABC’s “Good Morning America” program, Fauci reiterated the official narrative that no matter how much corruption and fraud is involved with the process, every Chinese virus injection presented to the public is still “safe and effective.”
Even though the DSMB “got concerned and wrote a rather harsh note,” Fauci says there is nothing to worry about because the injection in question is already being mass produced and thus must be plunged into people’s arms at warp speed if Big Pharma is going to realize the profits it craves.
More than a dozen countries throughout Europe are not buying what Fauci is trying to sell them, however. All of them suspended their AstraZeneca vaccination programs after it was revealed that many recipients were developing deadly blood clots or dying after injection.
The European Medicines Agency (EMA), like Fauci, still says the AstraZeneca jab is “safe and effective,” adding that the observed deadly side effects could not possibly be linked to the injection. The Food and Drug Administration (FDA) would likely say the same thing were the AstraZeneca jab being administered here, though it has not yet received approval.
This is soon to come, though, as the FDA is expected to issue emergency use authorization (EUA) for the AstraZeneca jab in a matter of weeks. Once approved, the jab will join three others from Pfizer and BioNTech, Moderna, and Johnson & Johnson (J&J) that have already received EUA from the FDA.
Currently, about 45 million people living in the U.S. have been injected with one of the aforementioned three jabs. Another 38 million are on the uniquely two-dose Pfizer/BioNTech track and have only received the first dose.
“Since they are immune to being sued, they can do whatever they want with impunity,” wrote one commenter at The Epoch Times about how these Big Pharma corporations are getting away with murder. “Neither Big Pharma nor social media should be immune to litigation.”
More related news about AstraZeneca, Anthony Fauci, and the rest of the Big Pharma cabal can be found at Evil.news.
Sources for this article include:
Turite savo nuomone, (už ar, prieš) pasidalinkite su mumis, palikite komentarą, prisijunkite, rašykite bloge, pasirinkdami kategoriją. Pasidalinkite savo receptais, sveikatos patarimais, nutikimais, susidūrėte su paranormaliais, anomališkais ir kitais nekasdieniškais reiškiniais. Galite išversti iš užsienio kalbos, talpinkite su nuoroda. Laukiame Jūsų straipsnių, naujienų, apžvalgų ar istorijų!